Pédiatrie Neuroblastomes
J1O-MC-JZHD
Etude J1O-MC-JZHD : Phase 1 Study of Aurora Kinase A Inhibitor LY3295668 erbumine as a Single Agent and in Combination in Patients with Relapsed/Refractory Neuroblastoma
Paris
ISABELLE AERTS